Arizona State Retirement System Abb Vie Inc. Transaction History

Arizona State Retirement System

$14.3 Billion
Q1 2024

A detailed history of Arizona State Retirement System transactions in Abb Vie Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 506,650 shares of ABBV stock, worth $86.9 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

506,650

Previous 496,585 2.03%

Holding current value

$86.9 Million

Previous $77 Million 19.89%

% of portfolio

0.65%

Previous 0.59%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $1.61 Million - $1.83 Million	10,065 Added 2.03%	506,650 $92.3 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $385,555 - $434,225	-2,802 Reduced 0.56%	496,585 $77 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $652,587 - $755,465	-4,885 Reduced 0.97%	499,387 $74.4 Million
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $2.84 Million - $3.53 Million	21,402 Added 4.43%	504,272 $67.9 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $161,095 - $185,525	1,114 Added 0.23%	482,870 $77 Million

Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $195,017 - $233,876	1,410 Added 0.29%	481,756 $77.9 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $658,165 - $754,872	-4,904 Reduced 1.01%	480,346 $64.5 Million
Q2 2022 Jul 28, 2022	BUY	$137.62 - $174.96 $19,954 - $25,369	145 Added 0.03%	485,250 $74.3 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $146,497 - $181,762	1,110 Added 0.23%	485,105 $78.6 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $917,129 - $1.16 Million	-8,537 Reduced 1.73%	483,995 $65.5 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $236,740 - $268,735	-2,225 Reduced 0.45%	492,532 $53.1 Million
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $290,484 - $323,616	-2,761 Reduced 0.55%	494,757 $55.7 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $1.2 Million - $1.32 Million	-11,690 Reduced 2.3%	497,518 $53.8 Million
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $2.25 Million - $3.04 Million	-27,930 Reduced 5.2%	509,208 $54.6 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $10.5 Million - $12.3 Million	122,247 Added 29.46%	537,138 $47 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $10.9 Million - $14.6 Million	148,998 Added 56.04%	414,891 $40.7 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $760,519 - $1.15 Million	-11,791 Reduced 4.25%	265,893 $20.3 Million
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $116,273 - $145,483	1,612 Added 0.58%	277,684 $24.6 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $320,820 - $385,717	-5,094 Reduced 1.81%	276,072 $20.9 Million
Q2 2019 Jul 25, 2019	SELL	$65.7 - $83.98 $136,393 - $174,342	-2,076 Reduced 0.73%	281,166 $20.4 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $1.99 Million - $2.34 Million	-25,821 Reduced 8.35%	283,242 $22.8 Million
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $5.16 Million - $6.36 Million	-66,256 Reduced 17.65%	309,063 $28.5 Million
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $268,508 - $298,496	3,020 Added 0.81%	375,319 $35.5 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $3.39 Million - $4.01 Million	-37,787 Reduced 9.21%	372,299 $34.5 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $1.22 Million - $1.64 Million	-13,300 Reduced 3.14%	410,086 $38.8 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $2.53 Million - $2.77 Million	28,210 Added 7.14%	423,386 $40.9 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $27.6 Million - $35.3 Million	395,176	395,176 $35.1 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Abb Vie Inc. Transaction History